Drug-related administration to be deregulated

Published: 2008-05-19 07:00:00

Updated: 2008-05-19 07:00:00

The pharmaceutical industry is expected to enjoy deregulation as the Korea Food and Drug Administration has adopted a series of measures to overhaul drug-related administration since May 1.

·Approval of bioequivalence testing will be made available through the review of documents concerning sa...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK